FDA approves new treatment for relapsed follicular lymphoma
On Sept. 14, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa (copanlisib) for the treatment of…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.